Blog
RSS FeedPosted by Michael Wonder on 05 Apr 2026
‘Life-changing’ eczema drug for children caught in $16,000/year PBS limbo
5 April 2026 - A prescription medication for a debilitating skin condition that is listed on the PBS for adults ...
Posted by Michael Wonder on 03 Apr 2026
MHRA-NICE pathway opens for business – everything you need to know to get started
1 April 2026 - Today marks a significant milestone for patients, the NHS and the pharmaceutical industry. From 1 April 2026, ...
Posted by Michael Wonder on 02 Apr 2026
AbbVie's Epkinly gets health insurance coverage for DLBCL in Korea
1 April 2026 - AbbVie Korea said Wednesday that its bispecific antibody Epkinly (epcoritamab), will receive national health insurance coverage ...
Posted by Michael Wonder on 01 Apr 2026
New Zealand Pharmaceutical Schedule - 1 April 2026
1 April 2026 - The April 2026 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Apr 2026
Cheaper medicines for people fighting cancer and rare diseases
1 April 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians living with debilitating conditions including ...
Posted by Michael Wonder on 31 Mar 2026
Schedule of Pharmaceutical Benefits - 1 April 2026
1 April 2026 - The April 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Mar 2026
Roche Korea to launch reimbursed Vabysmo pre-filled syringe in April, expanding retinal treatment options
30 March 2026 - Roche Korea said Monday that the Ministry of Health and Welfare has approved national health insurance ...
Posted by Michael Wonder on 30 Mar 2026
Leading cancer drug subsidised for thousands of patients
29 March 2026 - Health Minister Mark Butler has expanded the PBS listing of a leading cancer drug, giving more than ...
Posted by Michael Wonder on 29 Mar 2026
Expanded immunotherapy PBS listing to treat more cancers
29 March 2026 - The Albanese Government is continuing to deliver cheaper medicines with thousands more Australians living with advanced ...
Posted by Michael Wonder on 25 Mar 2026
New public listings for Canadians living with pulmonary arterial hypertension
24 March 2026 - Merck announced today that British Columbia, Non-Insured Health Benefits (NIHB), Nova Scotia, Quebec and Veterans Affairs Canada ...
Posted by Michael Wonder on 23 Mar 2026
Enhertu now available in Japan as first antibody drug conjugate for the second-line treatment of patients with HER2 positive metastatic gastric cancer
23 March 2026 - Based on DESTINY-Gastric04 Phase 3 trial results that showed Enhertu demonstrated statistically significant and clinically meaningful ...
Posted by Michael Wonder on 18 Mar 2026
When generic versions of weight loss drugs arrive, public plans should cover them, experts say
17 March 2026 - When Bonnie Evoy entered her mid 60s, she unexpectedly and rapidly gained weight. She tried for ...
Posted by Michael Wonder on 18 Mar 2026
Patients to get new medicines up to six months sooner
17 March 2026 - Patients in England are set to receive some new medicines 3 to 6 months earlier under a ...
Posted by Michael Wonder on 17 Mar 2026
PBAC advice on equitable access to GLP-1 obesity treatments
17 March 2026 - On 6 March 2025, Minister Butler wrote to the PBAC to request the Committee’s advice on ...
Posted by Michael Wonder on 11 Mar 2026
PHARMAC to fund life‑changing treatments for children with cystic fibrosis
11 March 2026 - PHARMAC will fund new treatment options for people living with cystic fibrosis from 1 April 2026. ...